Catalog Number 21AGFN-756 |
Device Problem
Physical Resistance/Sticking (4012)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/14/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
It was reported that on (b)(6) 2023, a 21mm sjm regent heart valve with flex cuff was selected for an implant.It was noted that during device preparation the leaflet function for the initial valve was tested using a non-abbott rubber sleeve and found that the leaflets were not moving normally.During the procedure, after implantation, it was found that the leaflets did not open and close well.The device was explanted and physician replaced with a new 21mm sjm regent heart valve with flex cuff that successfully completed the procedure.The patient was noted to be taking warfarin as their anti-thrombotic medication.The patient's latest international normalized ratio (inr) was between 2.0-3.0.The patient is stable at the time of report.No additional information was provided.
|
|
Manufacturer Narrative
|
An event was reported where it was observed that the leaflets were not coapting well.Subsequently post-implant revealed inadequate opening and closing of leaflets.The device was received for investigation and no anomalies were found.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Hydrodynamic testing upon return to abbott and at the time of manufacturing indicated the valve functioned normally.This test ensures proper leaflet coaptation and hemodynamic performance.The cause of the reported event could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
|
|
Search Alerts/Recalls
|